Catalyst Wire Dossier Catalyst Wire Dossier

dalafenib

dalafenib
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for dalafenib, covering 2024-02-20 to 2024-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma [Phase 3]

See pricing